-
Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES TrialGG Schwartz, PG Steg, ODYSSEY OUTCOMES Committees and Investigators et al. -
Linking Spontaneous Coronary Artery Dissection, Cervical Artery Dissection, and Fibromuscular Dysplasia: Heart, Brain, and KidneysParé G, Bhatt DL.
-
Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly PatientsShavadia JS, Holmes DN, Thomas L et al.
-
The Prognostic Significance of Periprocedural Infarction in the Era of Potent Antithrombotic Therapy: The PRAGUE-18 SubstudyJ Dusek, Z Motovska, Prague-18 Study Group et al.
-
Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary AngiographyRHM Furtado, JC Nicolau, JP Guo et al.
-
Invasive Versus Medical Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary Syndrome: A Pilot Randomized Controlled TrialLee MM, Petrie MC, Rocchiccioli P et al.
-
Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin IY Sandoval, R Nowak, CR deFilippi et al.
-
Long-term outcomes after myocardial infarction in middle-aged and older patients with congenital heart disease-a nationwide studyM Fedchenko, Z Mandalenakis, KW Giang et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
